|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C12N 15/10 | (2006.01) |
| (11) | Number of the document | 3488443 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17743311.7 |
| Date of filing the European patent application | 2017-07-19 | |
| (97) | Date of publication of the European application | 2019-05-29 |
| (45) | Date of publication and mention of the grant of the patent | 2021-08-18 |
| (46) | Date of publication of the claims translation | 2021-10-25 |
| (86) | Number | PCT/EP2017/068226 |
| Date | 2017-07-19 |
| (87) | Number | WO 2018/015433 |
| Date | 2018-01-25 |
| (30) | Number | Date | Country code |
| PCT/EP2016/067348 | 2016-07-20 | WO |
| (72) |
TADMOR, Arbel D. , DE
SAHIN, Ugur , DE
|
| (73) |
BioNTech SE ,
An der Goldgrube 12, 55131 Mainz,
DE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Neoepitopų, kaip ligai specifinių taikinių, parinkimas padidinto efektyvumo terapijai |
| SELECTING NEOEPITOPES AS DISEASE-SPECIFIC TARGETS FOR THERAPY WITH ENHANCED EFFICACY |
| Payment date | Validity (years) | Amount | |
| 2025-06-19 | 9 | 208.00 EUR |
| 2026-07-19 |